Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550147 · ClinicalTrials.gov registry record · Phase 2
Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00550147 is a Phase 2 study that has completed, run by Indiana University. The registered enrollment target is 30 participants.
The verdict
NCT00550147, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this thirteen-week, open-label study is to test the hypothesis that quetiapine in combination with Oros methylphenidate will reduce aggressive symptoms in children and adolescents who have shown inadequate response to OROS methylphenidate alone.
Interventions
- DRUG quetiapine
- DRUG Oros Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-02 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550147
The ClinicalTrials.gov registry entry for NCT00550147 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quetiapine is the first listed.
NCT00550147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550147 about?
NCT00550147 is a clinical study titled "Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.". The primary purpose of this thirteen-week, open-label study is to test the hypothesis that quetiapine in combination with Oros methylphenidate will reduce aggressive symptoms in children and adolescents who have shown inadequate response to OROS methylphenidate alone.
What is the current status of trial NCT00550147?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2004-02. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00550147?
The interventions under investigation include: quetiapine (DRUG), Oros Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00550147?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.